The Metabolic Syndrome and Cardiovascular Risk in Cushing's Syndrome

Pivonello, Rosario; Faggiano, Antongiulio; Lombardi, Gaetano; Colao, Annamaria

doi:10.1016/j.ecl.2005.01.010

Cited by 174Pituitary Gland Disorders and TreatmentsDiabetes, Cardiovascular Risks, and LipoproteinsAdrenal and Paraganglionic Tumors

The Metabolic Syndrome and Cardiovascular Risk in Cushing's Syndrome

Pivonello, Rosario, Faggiano, Antongiulio, Lombardi, Gaetano, Colao, Annamaria·2005·Endocrinology and Metabolism Clinics of North America

DOI 10.1016/j.ecl.2005.01.010

Open this paper in CoChat — free account

Abstract

Cushing's syndrome (CS) is characterized by a series of systemic complications that increase cardiovascular risk and cause severe atherosclerotic damage that develops in parallel with an acquired metabolic syndrome. Short-term remission from hypercortisolism improves metabolic and vascular damages, but long-term remission from CS seems to be associated with similar or worse metabolic and vascular damage, probably because of persistent abdominal obesity or insulin resistance years after normalization of cortisol secretion. Study results suggest that an increased cardiovascular risk also may persist in patients who undergo treatment with exogenous glucocorticoids after therapy withdrawal. Considering the many patients subjected to corticosteroid treatment, this could be of great clinical relevance and should be investigated thoroughly.

Integrity signals

Registry

Crossref · 10.1016/j.ecl.2005.01.010

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Surgical remission does not eliminate the risk of complications from systemic comorbidities completely.
“Surgical remission does not eliminate the risk of complications from systemic comorbidities completely (12, 13).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [13]

Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801 · see citing works
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · see citing works
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 1× · see citing works
“Impaired vasodilation after acetylcholine or hyperemia [39], enhanced large artery stiffness [40], and increased thrombotic diatesis [41] have been demonstrated in all states associated with metabolic syndrome/ insulin resistance development, such as obesity [42], impairment of glucose tolerance [43], diabetes mellitu…”
Background
The metabolic syndrome: prevalence in worldwide populations
Cameron, A. J., Shaw, J. E., & Zimmet, P. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.005 · Cited by 1,000 · see citing works
Incidence and late prognosis of cushing's syndrome: a population-based study.
Lindholm, J., Juul, S., Jørgensen, J., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kostel-janetz, M., Kristensen, L., et al. (2001) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 755 · see citing works
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 727 · see citing works
Diabetes and Endothelial Dysfunction: A Clinical Perspective
Calles-Escandón, J., & Cipolla, M. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0417 · Cited by 657 · see citing works
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622 · see citing works
Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 505 · see citing works
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study
Souverein, P. C., Bérard, A., van Staa, T. P., Cooper, C. C., Egberts, T. C. G., Leufkens, H. G. M., & Walker, B. (2004) · Heart · doi:10.1136/hrt.2003.020180 · Cited by 478 · see citing works
Persistence of Increased Cardiovascular Risk in Patients with Cushing's Disease after Five Years of Successful Cure
Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Cerbone, G., Siciliani, M., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5896 · Cited by 448 · see citing works
Self-citation
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus
Doria, A., Shoenfeld, Y., Wu, R., Gambari, P. F., Puato, M., Ghirardello, A., Gilburd, B., Corbanese, S., Patnaik, M., Zampieri, S., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1071 · Cited by 403 · see citing works
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission
Faggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021558 · Cited by 358 · see citing works
Self-citation
Splanchnic insulin metabolism in obesity. Influence of body fat distribution.
Peiris, A. N., Mueller, R. A., Smith, G. A., Struve, M. F., & Kissebah, A. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112758 · Cited by 346 · see citing works
Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome
KHANI, S., & TAYEK, J. A. (2001) · Clinical Science · doi:10.1042/cs1010739 · Cited by 259 · cited 1× · see citing works
“In patients who have hypercortisolism, insulin resistance and abdominal obesity induce gluconeogenesis [19] and promote a cascade of metabolic abnormalities that results in an overt metabolic syndrome.”
Background
Endothelial dysfunction in diabetes mellitus.
Cosentino, F., & Lüscher, T. F. (1998) · PubMed · Cited by 259 · see citing works
The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography
Troxler, R. G., Sprague, E. A., Albanese, R. A., FUCHS, R., & THOMPSON, A. (1977) · Atherosclerosis · doi:10.1016/0021-9150(77)90098-3 · Cited by 219 · see citing works
Regulation of 11β‐HSD Genes in Human Adipose Tissue: Influence of Central Obesity and Weight Loss
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Heintze, U., Janke, J., Luft, F. C., & Sharma, A. M. (2004) · Obesity Research · doi:10.1038/oby.2004.3 · Cited by 211 · see citing works
Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients
Suliman, M. E., Qureshi, A. R., Barany, P. F., Stenvinkel, P., Filho, J. C. D., Anderstam, B., Heimbürger, O., Lindholm, B., & Bergström, J. P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00018.x · Cited by 206 · see citing works
Impaired Endothelium-Dependent Vasodilatation in Women With Previous Gestational Diabetes
Anastasiou, E., Lekakis, J. P., Alevizaki, M., Papamichael, C. M., Megas, J., Souvatzoglou, A., & Stamatelopoulos, S. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2111 · Cited by 188 · see citing works
Is atherosclerosis a complication of long-term corticosteroid treatment?
Nashel, D. J. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90639-x · Cited by 185 · see citing works
Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity.
Westerbacka, J., Vehkavaara, S., Bergholm, R., Wilkinson, I. B., Cockcroft, J., & Yki‐Järvinen, H. (1999) · Diabetes · doi:10.2337/diabetes.48.4.821 · Cited by 151 · see citing works
Specific Impairment of Endothelium-Dependent Vasodilation in Subjects with Type 2 Diabetes Independent of Obesity
Hogikyan, R. V., Gałecki, A. T., Pitt, B., Halter, J. B., Greene, D. A., & Supiano, M. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4907 · Cited by 149 · see citing works
Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With Microalbuminuria
Kario, K., Matsuo, T., Kobayashi, H., Matsuo, M., Sakata, T., & Miyata, T. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1114 · Cited by 149 · see citing works
Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM
FRIEDMAN, T. C., MASTORAKOS, G., NEWMAN, T. D., MULLEN, N. M., HORTON, E. G., COSTELLO, R., PAPADOPOULOS, N. M., & CHROUSOS, G. P. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.645 · Cited by 145 · see citing works
Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
Ferri, C., Desideri, G., Baldoncini, R., Bellini, C., Angelis, C. D., Mazzocchi, C., & Santucci, A. (1998) · Diabetes · doi:10.2337/diabetes.47.4.660 · Cited by 127 · see citing works
11?-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
Stulnig, T. M., & Waldh�usl, W. (2004) · Diabetologia · doi:10.1007/s00125-003-1284-4 · Cited by 123 · see citing works
11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
Wake, D. J., & Walker, B. R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.015 · Cited by 111 · see citing works
Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy.
Kalbak, K. (1972) · Annals of the Rheumatic Diseases · doi:10.1136/ard.31.3.196 · Cited by 108 · see citing works
Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus
Tsakraklides, V., Blieden, L. C., & Edwards, J. E. (1974) · American Heart Journal · doi:10.1016/0002-8703(74)90504-3 · Cited by 95 · see citing works
Markers of activation of coagulation and fibrinolysis in patients with Cushing’s syndrome
Fatti, L. M., Bottasso, B., Invitti, C., Coppola, R., Cavagnini, F., & Mannucci, P. M. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343697 · Cited by 90 · see citing works
The Glucocorticoid Receptor Gene and Its Association to Metabolic Syndrome
Rosmond, R. (2002) · Obesity Research · doi:10.1038/oby.2002.146 · Cited by 89 · see citing works
Glucocorticoid metabolism and the Metabolic Syndrome: associations in an elderly cohort
Andrew, R., Galé, C. R., Walker, B. R., Seckl, J. R., & Martyn, C. N. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-34591 · Cited by 78 · see citing works
Hyperhomocysteinemia in Patients with Cushing’s Syndrome
Terzolo, M., Allasino, B., Bosio, S., Brusa, E., Daffara, F., Ventura, M., Aroasio, E., Sacchetto, G., Reimondo, G., Angeli, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0079 · Cited by 75 · see citing works
Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men.
Boyko, E. J., Leonetti, D. L., Bergstrom, R. W., Newell-Morris, L., & Fujimoto, W. Y. (1996) · Diabetes · doi:10.2337/diab.45.8.1010 · Cited by 61 · see citing works
Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus
Sella, E. M. C., Sato, E. I., Leite, W. A., Filho, J. A. O., & Barbieri, A. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1066 · Cited by 49 · see citing works
Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease
Colao, A., Pivonello, R., Faggiano, A., Filippella, M., Ferone, D., Somma, C. D., Cerbone, G., Marzullo, P., Fenzi, G., & Lombardi, G. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01018.x · Cited by 48 · see citing works
Self-citation
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome
Aguilar-Salinas, C. A., Rojas, R., Gomez-Perez, F. J., Valles, V., Rı́os-Torres, J. M., Franco, A., Oláiz, G., Rull, J. A., & Sepúlveda, J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1635 · Cited by 47 · see citing works
The metabolic syndrome
Garber, A. J. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.001 · Cited by 43 · see citing works
Effects of Cortisone, Hydrocortisone and Corticotropin on Lipemia, Glycemia and Atherogenesis in Cholesterol-Fed Chicks
Stamler, J., Pick, R. L., & Katz, L. N. (1954) · Circulation · doi:10.1161/01.cir.10.2.237 · Cited by 41 · see citing works
Effect of glucocorticoid excess on the cortisol/cortisone ratio
Dötsch, J., Dörr, H. G., Stalla, G. K., & Sippell, W. G. (2001) · Steroids · doi:10.1016/s0039-128x(01)00117-9 · Cited by 35 · see citing works
The Metabolic Syndrome X And Peripheral Cortisol Synthesis
Bähr, V., Pfeiffer, A. F. H., & Diederich, S. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-34996 · Cited by 31 · see citing works
Enhancement of Experimental Atherosclerosis by ACTH in the Dog.
Rosenfeld, S., Marmorston, J., Sobel, H., & White, A. (1960) · Experimental Biology and Medicine · doi:10.3181/00379727-103-25420 · Cited by 30 · see citing works
Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes
Davidson, M. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3179 · Cited by 30 · see citing works
Risk Factors Associated with Persistent Postoperative Hypertension in Cushing's Syndrome
Suzuki, T., Shibata, H., Ando, T., Kurihara, I., Kobayashi, S., Hayashi, K., Hayashi, M., Kawabe, H., Saito, I., Murai, M., et al. (2000) · Endocrine Research · doi:10.3109/07435800009048601 · Cited by 22 · see citing works
Insulin Resistance in Cushing's Syndrome
Karnieli, E., Cohen, P., Barzilai, N., Ish-Shalom, Z., Armoni, M., Rafaelov, R., & Barzilai, D. (1985) · Hormone and Metabolic Research · doi:10.1055/s-2007-1013593 · Cited by 17 · see citing works
Glucose metabolism in patients with Cushing's syndrome
Bowes, S. B., Benn, J. J., Scobie, I. N., Umpleby, A. M., Lowy, C., & Sönksen, P. H. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03772.x · Cited by 11 · see citing works
[Metabolic syndrome: definitions and epidemiological data].
Scheen, A. J., & Luyckx, F. (2003) · PubMed · Cited by 10 · see citing works
Effect of glucocorticoids on human vascular connective tissue. Biochemical and microscopic studies of vein biopsies.
Lorenzen, I., & Lk, H. (1967) · PubMed · Cited by 9 · see citing works

Flagged first, then by citations

1 of the 51 references couldn’t be matched to a known paper.

Sorted by citations

Complications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., Martino, M. C. D., Newell-Price, J. D. C., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 694 · see citing works
Self-citation
The Treatment of Cushing's Disease
Pivonello, R., Leo, M. D., Cozzolino, A., & Colao, A. A. L. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 471 · see citing works
Self-citation
Mechanisms of Glucocorticoid-Induced Insulin Resistance
Geer, E. B., Islam, J., & Buettner, C. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.005 · Cited by 392 · see citing works
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Morand, E. F., Leech, M. T., & Bernhagen, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2029 · Cited by 347 · see citing works
The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
Pivonello, R., Martino, M. C. D., Cappabianca, P., Leo, M. D., Faggiano, A., Lombardi, G., Hofland, L. J., Lamberts, S. W. J., & Colao, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1533 · Cited by 328 · see citing works
Self-citation
Atrophy and Impaired Muscle Protein Synthesis during Prolonged Inactivity and Stress
Paddon-Jones, D., Sheffield-Moore, M., Cree, M. G., Hewlings, S. J., Aarsland, A., Wolfe, R. R., & Ferrando, A. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0651 · Cited by 254 · see citing works
Approach to the Patient with Possible Cushing’s Syndrome
Boscaro, M., & Arnaldi, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0612 · Cited by 251 · see citing works
Cortisol, obesity, and the metabolic syndrome: A cross‐sectional study of obese subjects and review of the literature
Abraham, S. B., Rubino, D., Sinaii, N., Ramsey, S., & Nieman, L. K. (2013) · Obesity · doi:10.1002/oby.20083 · Cited by 225 · see citing works
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196 · see citing works
Cushing's Syndrome
Pivonello, R., De Martino, M. C., De Leo, M., Lombardi, G., & Colao, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.010 · Cited by 195 · see citing works
Self-citation
The hypertension of Cushing's syndrome
Isidori, A. M., Graziadio, C., Paragliola, R. M., Cozzolino, A., Ambrogio, A. G., Colao, A., Corsello, S. M., & Pivonello, R. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000415 · Cited by 220 · see citing works
Self-citation
Predictors of Mortality and Long-term Outcomes in Treated Cushing's Disease: A Study of 346 Patients
Lambert, J. K., Goldberg, L., Fayngold, S., Kostadinov, J., Post, K. D., & Geer, E. B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2893 · Cited by 185 · see citing works
Metabolic comorbidities in Cushing's syndrome
Ferraù, F., & Korbonits, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0354 · Cited by 223 · see citing works
Neuropsychiatric disorders in Cushing's syndrome
Pivonello, R., Simeoli, C., Martino, M. D. D., Cozzolino, A., de Leo, M., Iacuaniello, D., Pivonello, C., Negri, M., Pellecchia, M. T., Iasevoli, F., et al. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00129 · Cited by 116 · see citing works
Self-citation
AMP‐activated protein kinase mediates glucocorticoid‐ induced metabolic changes: a novel mechanism in Cushing's syndrome
Christ‐Crain, M., Kola, B., Lolli, F., Fekete, C., Seboek, D., Wittmann, G., Feltrin, D., Igreja, S., Ajodha, S. J., Harvey-White, J. D., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-094144 · Cited by 170 · see citing works
Persistent Body Fat Mass and Inflammatory Marker Increases after Long-Term Cure of Cushing’s Syndrome
Barahona, M. J., Sucunza, N., Resmini, E., Fernández‐Real, J. M., Ricart, W., Moreno‐Navarrete, J. M., Puig, T., Farrerons, J., & Webb, S. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0766 · Cited by 161 · see citing works
Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence.
Petersenn, S., Beckers, A., Ferone, D., van der Lely, A. J., Bollerslev, J., Boscaro, M., Brue, T., Bruzzi, P., Casanueva, F., Chanson, P., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0883 · Cited by 141 · see citing works
Self-citation
Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations
Colao, A., Block, C. E. M. D., Gaztambide, M. S., Kumar, S., Seufert, J., & Casanueva, F. F. (2013) · Pituitary · doi:10.1007/s11102-013-0483-3 · Cited by 150 · see citing works
Self-citation
Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up
Ntali, G., Asimakopoulou, A., Siamatras, T., Komninos, J., Vassiliadi, D., Tzanela, M., Tsagarakis, S., Grossman, A. B., Wass, J. A. H., & Karavitaki, N. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0569 · Cited by 149 · see citing works
Association between the Metabolic Syndrome and Serum Cortisol in Overweight Latino Youth
Weigensberg, M. J., Toledo‐Corral, C. M., & Goran, M. I. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2309 · Cited by 128 · see citing works
Chronic glucocorticoid treatment induced circadian clock disorder leads to lipid metabolism and gut microbiota alterations in rats
Wu, T., Yang, L., Jiang, J., Ni, Y., Zhu, J., Zheng, X., Wang, Q., Lu, X., & Fu, Z. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.11.049 · Cited by 126 · see citing works
Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case–control study
Nadareishvili, Z., Michaud, K. D., Hallenbeck, J. M., & Wolfe, F. (2008) · Arthritis Care & Research · doi:10.1002/art.23935 · Cited by 119 · see citing works
Metabolic Syndrome in Cushing’s Syndrome
Chanson, P., & Salenave, S. (2010) · Neuroendocrinology · doi:10.1159/000314272 · Cited by 118 · see citing works
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study
Pivonello, R., Petersenn, S., Newell-Price, J. D. C., Findling, J. W., Gu, F., Maldonado, M., Trovato, A., Hughes, G., Salgado, L. R., Lacroix, A., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12431 · Cited by 117 · see citing works
Self-citation
Cardiovascular Disease in Cushing’s Syndrome: Heart versus Vasculature
de Leo, M., Pivonello, R., Auriemma, R., Cozzolino, A., Vitale, P., Simeoli, C., Martino, M. D. D., Lombardi, G., & Colao, A. (2010) · Neuroendocrinology · doi:10.1159/000318566 · Cited by 100 · see citing works
Self-citation
Cortisol Is Negatively Associated with Insulin Sensitivity in Overweight Latino Youth
Adam, T. C., Hasson, R. E., Ventura, E. E., Toledo-Corral, C., Le, K.-A., Mahurkar, S., Lane, C. J., Weigensberg, M. J., & Goran, M. I. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0322 · Cited by 95 · see citing works
Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus
Reimondo, G., Pia, A., Allasino, B., Tassone, F., Bovio, S., Borretta, G., Angeli, A., & Terzolo, M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02865.x · Cited by 89 · see citing works
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Pernicova, I., Kelly, S., Ajodha, S. J., Sahdev, A., Bestwick, J. P., Gabrovska, P. N., Akanle, O., Ajjan, R., Kola, B., Stadler, M., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30021-8 · Cited by 90 · see citing works
Approach to the Patient: Diagnosis of Cushing Syndrome
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac492 · Cited by 91 · see citing works
Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications
Arnaldi, G., Mancini, T., Tirabassi, G., Trementino, L., & Boscaro, M. (2012) · Journal of Endocrinological Investigation · doi:10.1007/bf03345431 · Cited by 85 · see citing works
Cushing's syndrome: aftermath of the cure
Pivonello, R., De Martino, M. C., De Leo, M., Tauchmanovà, L., Faggiano, A., Lombardi, G., & Colao, A. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800025 · Cited by 85 · see citing works
Self-citation
Managing Cushing’s disease: the state of the art
Colao, A., Boscaro, M., Ferone, D., & Casanueva, F. F. (2014) · Endocrine · doi:10.1007/s12020-013-0129-2 · Cited by 66 · see citing works
Self-citation
Subclinical Cushing’s syndrome
Leo, M. D., Cozzolino, A., Colao, A. A. L., & Pivonello, R. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.02.001 · Cited by 63 · see citing works
Self-citation
Metabolic, Cardiovascular, and Cerebrovascular Outcomes in Growth Hormone-Deficient Subjects with Previous Cushing’s Disease or Non-Functioning Pituitary Adenoma
Webb, S. M., Mo, D., Lamberts, S. W. J., Melmed, S. K., Cavagnini, F., Giraldi, F. P., Strasburger, C. J., Zimmermann, A. G., Woodmansee, W. W., & on behalf of the International HypoCCS Advisory Board (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0806 · Cited by 63 · see citing works
Increased cortisol level
Cagnacci, A., Cannoletta, M., Caretto, S., Zanin, R., Xholli, A., & Volpe, A. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181f31947 · Cited by 61 · see citing works
Clinical consequences of Cushing’s syndrome
Valassi, E., Crespo, I., Vives, A. S., & Webb, S. M. (2012) · Pituitary · doi:10.1007/s11102-012-0394-8 · Cited by 60 · see citing works
Pros and cons of screening for occult Cushing syndrome
Tabarin, A., & Perez, P. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.51 · Cited by 57 · see citing works
Chronic glucocorticoid treatment enhances lipogenic activity in visceral adipocytes of male Wistar rats
Chimin, P., de Farias, T. D. S. M., Torres‐Leal, F. L., Lopes, A. B., Campaña, A. B., Andreotti, S., & Lima, F. B. (2014) · Acta Physiologica · doi:10.1111/apha.12226 · Cited by 56 · see citing works
Blockade of Glucocorticoid Excess at the Tissue Level: Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 as a Therapy for Type 2 Diabetes
Fotsch, C. H., & Wang, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800369f · Cited by 55 · see citing works
Hyperaldosteronism and Hyperprogesteronism in a Cat
Briscoe, K., Barrs, V. R., Foster, D. F., & Beatty, J. A. (2009) · Journal of Feline Medicine and Surgery · doi:10.1016/j.jfms.2009.07.010 · Cited by 54 · see citing works
Adipokines and Cardiovascular Risk in Cushing’s Syndrome
Valassi, E., Biller, B. M. K., Klibanski, A., & Misra, M. (2011) · Neuroendocrinology · doi:10.1159/000330416 · Cited by 53 · see citing works
Sex‐ and age‐specific effects of nutrition in early gestation and early postnatal life on hypothalamo‐pituitary‐adrenal axis and sympathoadrenal function in adult sheep
Poore, K. R., Boullin, J. P., Cleal, J. K., Newman, J. P., Noakes, D. E., Hanson, M. A., & Green, L. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.187682 · Cited by 51 · see citing works
Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
Fallo, F., Dalmazi, G. D., Beuschlein, F., Biermasz, N. R., Castinetti, F., Elenkova, A. P., Faßnacht, M., Isidori, A. M., Kaštelan, D., Korbonits, M., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003252 · Cited by 48 · see citing works
Self-citation
Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess
Pivonello, R., Martino, M. C. D., Iacuaniello, D., Simeoli, C., Muscogiuri, G., Carlomagno, F., Leo, M. D., Cozzolino, A., & Colao, A. (2016) · Frontiers of hormone research · doi:10.1159/000443864 · Cited by 48 · see citing works
Self-citation
Mortality in Patients with Endogenous Cushing’s Syndrome
Javanmard, P., Duan, D., & Geer, E. B. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.02.005 · Cited by 47 · see citing works
Elevated Inflammation Markers in Pheochromocytoma Compared to Other Forms of Hypertension
Zelinka, T., Petrák, O., Štrauch, B., Holaj, R., Kvasnička, J., Mazoch, J., Pacák, K., & Widimsky, J., Jr. (2007) · NeuroImmunoModulation · doi:10.1159/000107289 · Cited by 46 · see citing works
Cushing's Syndrome
Findling, J. W., & Raff, H. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.015 · Cited by 43 · see citing works
Health care resource use and costs among patients with cushing disease.
Swearingen, B., Wu, N., Chen, S.-Y., Pulgar, S., & Biller, B. (2011) · Endocrine Practice · doi:10.4158/ep10368.or · Cited by 41 · see citing works
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome
Guarnotta, V., Amato, M. C., Pivonello, R., Arnaldi, G., Ciresi, A., Trementino, L., Citarrella, R., Iacuaniello, D., Michetti, G., Simeoli, C., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0914-9 · Cited by 42 · see citing works
Self-citation
Cardiovascular autonomic function in Cushing’s syndrome
Fallo, F., Maffei, P., Pozza, A. D., Carli, M., Mea, P. D., Lupia, M., Rabbia, F., & Sonino, N. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345677 · Cited by 38 · see citing works
Quality of Life and Other Outcomes in Children Treated for Cushing Syndrome
Keil, M. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1123 · Cited by 38 · see citing works
CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus
Scerif, M., Füzesi, T., Thomas, J., Kola, B., Grossman, A. B., Fekete, C., & Korbonits, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0192 · Cited by 36 · see citing works
Effect of cabergoline monotherapy in Cushing’s disease: an individual participant data meta-analysis
Palui, R., Sahoo, J., Kamalanathan, S., Kar, S. S., Selvarajan, S., & Durgia, H. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0936-7 · Cited by 36 · see citing works
Circadian Blood Pressure Profile in Patients with Active Cushing's Disease and after Long-term Cure
Giraldi, F. P., Toja, P. M., Martin, M., Maronati, A., Scacchi, M., Omboni, S., Cavagnini, F., & Parati, G. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-992813 · Cited by 37 · see citing works
The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats
Beebe, K. D., Block, T. S., DeBattista, C., Blasey, C. M., & Belanoff, J. K. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.039 · Cited by 35 · see citing works
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease.
Faggiano, A., Melis, D., Alfieri, R., Martino, M. D. D., Filippella, M., Milone, F., Lombardi, G., Colao, A., & Pivonello, R. (2005) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2005-0656 · Cited by 48 · see citing works
Self-citation
Sustained weight loss in patients treated with mifepristone for Cushing’s syndrome: a follow-up analysis of the SEISMIC study and long-term extension
Fein, H. G., Vaughan, T. B., Kushner, H., Cram, D., & Nguyen, D. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0059-5 · Cited by 32 · see citing works
Pathophysiology, Evaluation, and Medical Management of Adrenal Disorders
Kutikov, A., Crispen, P. L., & Uzzo, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00057-8 · Cited by 31 · see citing works
The New Molecular Landscape of Cushing's Disease
Sbiera, S., Deutschbein, T., Weigand, I., Reincke, M., Faßnacht, M., & Allolio, B. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.08.003 · Cited by 31 · see citing works
Coronary microvascular function in patients with Cushing’s syndrome
Fallo, F., Famoso, G., Capizzi, D., Sonino, N., Dassie, F., Maffei, P., Martini, C., Paoletta, A., Iliceto, S., & Tona, F. (2012) · Endocrine · doi:10.1007/s12020-012-9764-2 · Cited by 30 · see citing works
High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery
Isand, K., Feelders, R. A., Brue, T. C., Tóth, M., Deutschbein, T., Reincke, M., Kršek, M., Vives, A. S., Demtröder, F., Chabre, O., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad176 · Cited by 30 · see citing works
Accuracy of immunoassay and mass spectrometry urinary free cortisol in the diagnosis of Cushing’s syndrome
Aranda, G. B., Careaga, M., Hanzu, F. A., Patrascioiu, I., Ríos, P., Mora, M., Morales‐Romero, B., Jiménez, W., Halperín, I., & Casals, G. (2016) · Pituitary · doi:10.1007/s11102-016-0730-5 · Cited by 27 · see citing works
Medical treatment of Cushing's disease: Overview and recent findings
Heaney, A. P. (2009) · International Journal of General Medicine · doi:10.2147/ijgm.s7545 · Cited by 25 · see citing works
Pancreatic endocrine function in newborn pony foals after induced or spontaneous delivery at term
Holdstock, N. B., Allen, V. L., & Fowden, A. L. (2012) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.2011.00447.x · Cited by 25 · see citing works
Long-term hypercortisolism induces lipogenesis promoting palmitic acid accumulation and inflammation in visceral adipose tissue compared with HFD-induced obesity
García-Eguren, G., Sala‐Vila, A., Giró, O., Vega‐Beyhart, A., & Hanzu, F. A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00516.2019 · Cited by 24 · see citing works
Serum adipokine concentrations in dogs with naturally occurring pituitary-dependent hyperadrenocorticism
Cho, K.-D., Paek, J., Kang, J.-H., Chang, D., Na, K.-J., & Yang, M.-P. (2014) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12270 · Cited by 24 · see citing works
Body Composition After Endogenous (Cushing's Syndrome) and Exogenous (Rheumatoid Arthritis) Exposure to Glucocorticoids
Resmini, E., Farkas, C., Murillo, B. D., Barahona, M. J., Vives, A. S., Martínez-Momblán, M.-A., Roig, O., Ybarra, J., Geli, C., & Webb, S. M. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1255032 · Cited by 24 · see citing works
Increased Osteoprotegerin Levels in Cushing’s Syndrome Are Associated with an Adverse Cardiovascular Risk Profile
Dovio, A., Allasino, B., Palmas, E., Ventura, M., Pia, A. R., Saba, L., Aroasio, E., Terzolo, M., & Angeli, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2283 · Cited by 24 · see citing works
Surgical remission of Cushing's syndrome reduces cardiovascular risk
Terzolo, M., Allasino, B., Pia, A., Peraga, G., Daffara, F., Laino, F., Ardito, A., Termine, A., Paccotti, P., Berchialla, P., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0555 · Cited by 22 · see citing works
Corticosterone accelerates atherosclerosis in the apolipoprotein E-deficient mouse
Okutsu, M., Lira, V. A., Higashida, K., Peake, J. M., Higuchi, M., & Suzuki, K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.076 · Cited by 23 · see citing works
Chronic hypercortisolism causes more persistent visceral adiposity than HFD-induced obesity
García-Eguren, G., Giró, O., Romero, M. D. M., Grasa, M., & Hanzu, F. A. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0168 · Cited by 23 · see citing works
Second-line treatment for Cushing's disease when initial pituitary surgery is unsuccessful
Fleseriu, M., Loriaux, D. L., & Ludlam, W. H. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328248b498 · Cited by 22 · see citing works
Pasireotide for the treatment of Cushing's disease
Arnaldi, G., & Boscaro, M. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.495943 · Cited by 22 · see citing works
Decreased Autonomic Modulation of Heart Rate and Altered Cardiac Sympathovagal Balance in Patients with Cushing's Syndrome: Role of Endogenous Hypercortisolism
Chandran, D., Ali, N., Jaryal, A., Jyotsna, V., & Deepak, K. (2013) · Neuroendocrinology · doi:10.1159/000345905 · Cited by 21 · see citing works
A direct comparison of quality of life in obese and Cushing's syndrome patients
Abraham, S. B., Abel, B. S., Rubino, D., Nansel, T. R., Ramsey, S., & Nieman, L. K. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1078 · Cited by 22 · see citing works
Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing’s syndrome
Roerink, S. H. P. P., Wagenmakers, M. A. E. M., Smit, J. W. A., van Rossum, E. F. C., Netea-Maier, R. T., Plantinga, T. S., & Hermus, A. R. M. M. (2016) · Endocrine · doi:10.1007/s12020-016-0883-z · Cited by 22 · see citing works
The treatment with pasireotide in Cushing’s disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single center
Simeoli, C., Ferrigno, R., Martino, M. C. D., Iacuaniello, D., Papa, F., Angellotti, D., Pivonello, C., Patalano, R., Negri, M., Colao, A. A. L., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01077-8 · Cited by 22 · see citing works
Self-citation
Persistence of Cushing’s Disease Symptoms and Comorbidities After Surgical Cure: a Long-Term, Integral Evaluation
Laura, E., Sosa, E., Nayeli, M., & Moisés, M. (2013) · Endocrine Practice · doi:10.4158/ep12247.or · Cited by 22 · see citing works
Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome
Camozzi, V., Sanguin, F., Albigier, N., Scaroni, C. M., Mantero, F., Zaninotto, M., Frigo, A., Piccolo, M., & Luisetto, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0800 · Cited by 21 · see citing works
Translational evidence of prothrombotic and inflammatory endothelial damage in Cushing syndrome after remission
Aranda, G. B., Fernandez‐Ruiz, R., Palomo, M., Romo, M., Mora, M., Halperín, I., Casals, G., Enseñat, J., Vidal, Ó., Díaz‐Ricart, M., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13521 · Cited by 21 · see citing works
Lack of functional remission in Cushing’s syndrome
Vermalle, M., Alessandrini, M., Graillon, T., Paladino, N. C., Baumstarck, K., Sebag, F. A., Dufour, H., Brue, T. C., & Castinetti, F. (2018) · Endocrine · doi:10.1007/s12020-018-1664-7 · Cited by 21 · see citing works
Cushing's syndrome might be underappreciated in patients seeking bariatric surgery: a plea for screening
Fleseriu, M., Ludlam, W. H., Teh, S. H., Yedinak, C. G., Deveney, C. W., & Sheppard, B. C. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2008.09.011 · Cited by 21 · see citing works
A novel use of etomidate for intentional adrenal suppression to control severe hypercortisolemia in childhood*
Mettauer, N. L., & Brierley, J. (2009) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e318198b096 · Cited by 19 · see citing works
Adrenocorticotropic hormone levels before treatment predict recurrence of Cushing's disease
Kuo, C., Shih, S., Li, H., Chen, S., Hung, P., Tseng, F., & Chang, T. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.08.008 · Cited by 19 · see citing works
Ambulatory Arterial Stiffness Indexes in Cushing’s Syndrome
Battocchio, M., Rebellato, A., Grillo, A., Dassie, F., Maffei, P., Bernardi, S., Fabris, B., Carretta, R., & Fallo, F. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-100385 · Cited by 18 · see citing works
Assessment of left ventricular functions by tissue Doppler echocardiography in patients with Cushing’s disease
Bayram, N., Ersoy, R., Aydın, C., Gül, K., Keleş, T., Topaloğlu, O., Durmaz, T., Bozkurt, E., & Cakir, B. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346461 · Cited by 18 · see citing works
Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism
José, P. G. S., Arenas, C., Moral, I. C., Álvaro, P. C., & Alenza, M. D. P. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15841 · Cited by 17 · see citing works
Cushing’s Disease: Assessment of Early Cardiovascular Hemodynamic Dysfunction With Impedance Cardiography
Jurek, A., Krzesiński, P., Gielerak, G. G., Witek, P., Zieliński, G., Kazimierczak, A., Wierzbowski, R., Banak, M., & Uziębło‐Życzkowska, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.751743 · Cited by 17 · see citing works
Impaired endothelium mediated vascular reactivity in endogenous Cushing's syndrome
Chandran, D. S., Jaryal, A. K., Jyotsna, V. P., & Deepak, K. K. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0030 · Cited by 17 · see citing works
Emerging drugs for Cushing’s disease
Guelho, D., & Grossman, A. B. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1047762 · Cited by 14 · see citing works
Adipokine and cytokine levels in patients with adrenocortical cancer, subclinical Cushing's syndrome and healthy controls
Babińska, A., Kaszubowski, M. F., Kmieć, P., & Sworczak, K. (2018) · Steroids · doi:10.1016/j.steroids.2018.08.011 · Cited by 14 · see citing works
Effectiveness of partial adrenalectomy for concomitant hypertension in patients with nonfunctional adrenal adenoma
Xu, T., Xia, L., Wang, X., Zhang, X., Zhong, S., Qin, L., Zhang, X., Zhu, Y., & Shen, Z. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0841-8 · Cited by 14 · see citing works
Quality of life in patients with Cushing's disease: a modern approach
Colao, A., Cozzolino, A., & Pivonello, R. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04344.x · Cited by 10 · see citing works
Self-citation
Bariatric surgery for obesity and hidden Cushing syndrome
Savastano, S., Pivonello, R., & Colao, A. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2008.07.006 · Cited by 14 · see citing works
Self-citation
Role of Diverse Smooth Muscle Cell Phenotypic Transitions in Atherosclerosis Development and Late-Stage Pathogenesis
Serbulea, V., Martin, J., & Owens, G. K. (2025) · Annual Review of Physiology · doi:10.1146/annurev-physiol-052824-084232 · Cited by 13 · see citing works
Cardiometabolic complications after Cushing’s disease remission
Tizianel, I., Lizzul, L., Mondin, A., Voltan, G., Mazzeo, P., Scaroni, C. M., Barbot, M., & Ceccato, F. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02572-x · Cited by 13 · see citing works
Routine screening for Cushing's syndrome is not required in patients presenting with hirsutism
Karaca, Z., Açmaz, B., Açmaz, G., Tanrıverdi, F., Unluhizarci, K., Aribaş, S., Sahin, Y., & Keleştimur, F. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0938 · Cited by 13 · see citing works
Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non‐HDL cholesterol and may diminish the association of HDL cholesterol with the –629C>A CETP promoter polymorphism in GH‐receiving hypopituitary patients
Dullaart, R. P. F., Schols, J. L., van der Steege, G., Zelissen, P. M. J., Sluiter, W. J., & van Beek, A. P. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03196.x · Cited by 13 · see citing works
Serum Adiponectin Level as a Predictor of Subclinical Cushing’s Syndrome in Patients with Adrenal Incidentaloma
Ünal, A. D., Aytürk, S., Aldemir, D., & Tütüncü, N. B. (2016) · International Journal of Endocrinology · doi:10.1155/2016/8519362 · Cited by 11 · see citing works
Bénéfices tensionnels, anthropométriques et métaboliques de l’exérèse chirurgicale des adénomes cortisoliques infracliniques
Mauclère-Denost, S., Duron-Martinaud, S., Nunes, M. L., Gatta‐Cherifi, B., Fagour, C., Rault, A., Gosse, P., & Tabarin, A. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.03.005 · Cited by 11 · see citing works

Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess
Pivonello, R., Martino, M. C. D., Iacuaniello, D., Simeoli, C., Muscogiuri, G., Carlomagno, F., Leo, M. D., Cozzolino, A., & Colao, A. (2016) · Frontiers of hormone research · doi:10.1159/000443864 · Cited by 48 · see citing works
Self-citation
Cardiovascular Disease in Cushing’s Syndrome: Heart versus Vasculature
de Leo, M., Pivonello, R., Auriemma, R., Cozzolino, A., Vitale, P., Simeoli, C., Martino, M. D. D., Lombardi, G., & Colao, A. (2010) · Neuroendocrinology · doi:10.1159/000318566 · Cited by 100 · see citing works
Self-citation
Cardiometabolic comorbidities in overt Cushing’s syndrome
Fernández, L. G., & Centeno, R. G. (2026) · Vitamins and hormones · doi:10.1016/bs.vh.2026.02.006
The Cardiovascular Risk in Cushing’s Syndrome
Dobrescu, M., Păun, D., Grigorie, D., Ghemigian, A., & Poiană, C. (2019) · Internal Medicine · doi:10.2478/inmed-2019-0058
Cardiometabolic Complications of Cushing's Syndrome: Mechanism and Management – A Systematic review
Dr. Mohamed Irshad Dr. Ayswarya, P. (2026) · International Journal of Medical Science in Clinical Research and Review · doi:10.5281/zenodo.18184186

Authors: Pivonello, R., Faggiano, A., Lombardi, G., & Colao, A.
Affiliations: Federico II University Hospital (IT)
Corresponding author: Pivonello, Rosario
ORCID: Pivonello, Rosario
Faggiano, Antongiulio
Colao, Annamaria
Venue: Endocrinology and Metabolism Clinics of North America
Publisher: Elsevier BV
Published: 2005-06
Volume: 34
Issue: 2
Pages: 327-339
ISSN: 0889-8529 (ISSN-L)
DOI: 10.1016/j.ecl.2005.01.010
OpenAlex: W1978784950
Cited by: 173
References: 51
Citations by year: 2026: 5 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 4 · 2021: 2 · 2020: 7 · 2019: 11 · 2018: 8 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 10 · 2013: 16 · 2012: 14
FWCI: 0.87
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Endocrinology and Metabolism Clinics of North America (publishedVersion)
PubMed (publishedVersion)
IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Keywords: Cushing's syndrome, metabolic syndrome, cardiovascular risk, hypercortisolism, atherosclerosis, abdominal obesity, insulin resistance, glucocorticoid therapy, remission, vascular injury
MeSH terms: Cardiovascular Diseases, Humans, Risk Factors, Metabolic Syndrome, Pituitary ACTH Hypersecretion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Metabolic Syndrome and Cardiovascular Risk in Cushing's Syndrome

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks